These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 313239)

  • 1. T and B-RFC inhibiting factor in plasma from patients with active Hodgkin's disease.
    Ezdinli EZ; Simonson KL; Simonson LG; Wasser LP
    Cancer; 1979 Jul; 44(1):106-11. PubMed ID: 313239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc gamma receptors on lymphocytes from normal donors and patients with lymphoproliferative diseases. Influence of incubation conditions.
    Smit JW; van der Giessen M; Halie MR
    Acta Haematol; 1983; 70(2):108-18. PubMed ID: 6223479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
    de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
    Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune function in patients with multiple myeloma (delayed cutaneous reactivity and lymphocytes bearing receptors for sheep, human and mouse erythrocytes).
    Dammacco F; Miglietta A; Bonomo L
    Ric Clin Lab; 1977; 7(4):343-53. PubMed ID: 307801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased autologous rosette-forming T lymphocytes in alcoholic cirrhosis: absence of correlation with other T cell markers and with delayed cutaneous hypersensitivity.
    Lang JM; Ruscher H; Hasselmann JP; Grandjean P; Bigel P; Mayer S
    Int Arch Allergy Appl Immunol; 1980; 61(3):337-43. PubMed ID: 6965492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peripheral blood T- and B-lymphocyte number in Hodgkin's disease].
    Dziewulska-Bokiniec A; Sztaba-Kania M
    Nowotwory; 1980; 30(2):155-9. PubMed ID: 6968060
    [No Abstract]   [Full Text] [Related]  

  • 10. Hodgkin's disease in children: investigation of T and B lymphocytes.
    Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
    Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
    Bodolay E; Berényi E; Sonkoly I; Szegedi G
    Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M; Piccioli E; Migliorati T; Ruggeri G
    Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rosette test in Hodgkin's disease. Relation to the presence of antilymphocyte antibodies].
    Manconi PE; Del Giacco GS; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):565-8. PubMed ID: 4615726
    [No Abstract]   [Full Text] [Related]  

  • 15. Human autologous rosettes. II. Prognostic significance of variations in autologous rosette-forming cells in the peripheral blood of cancer patients.
    Caraux J; Thierry C; Serrou B
    J Natl Cancer Inst; 1979 Sep; 63(3):593-7. PubMed ID: 314015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cytotoxic Hodgkin's serum on LIF activity of T- and B-lymphocytes].
    Chisesi T; Giacobbo M; Capnist T
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):428-33. PubMed ID: 310684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
    J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the high- and low-affinity rosette-forming T-lymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Kadhim S; Rees RC; Potter CW; Walker R; Hancock BW
    Eur J Cancer (1965); 1981 May; 17(5):569-75. PubMed ID: 6975211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.